NHUNG PHAM: Open Payments
NPI 1760034359 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,881 in 90 payments from 17 companies in 2025. Trend: 2023 $2,601 · 2024 $2,270 · 2025 $1,881
Food & beverage: $1,707Education: $174
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 24 | $301 |
| Janssen Biotech, Inc. | 5 | $259 |
| LEO Pharma Inc. | 11 | $200 |
| Incyte Corporation | 8 | $190 |
| Regeneron Pharmaceuticals, Inc. | 2 | $154 |
| Lilly USA, LLC | 9 | $137 |
| GENZYME CORPORATION | 4 | $134 |
| Novartis Pharmaceuticals Corporation | 6 | $121 |
| Regeneron Healthcare Solutions, Inc. | 4 | $103 |
| Organon LLC | 5 | $60 |
Products named: DUPIXENT, Zoryve, TREMFYA, OPZELURA, TALTZ, ADBRY, COSENTYX, ANZUPGO.
Industry payments across OK — which companies pay providers there.
